Sage Therapeutics CEO Jeffrey Jonas' 2019 pay rises 1% to $9.9M
Sage Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 29, 2021
Sage Therapeutics reported fiscal year 2019 executive compensation information on April 29, 2021.
In 2019, six executives at Sage Therapeutics received on average a compensation package of $5.1M, a 9% increase compared to previous year.
Average pay of disclosed executives at Sage Therapeutics
Jeffrey M. Jonas, Chief Executive Officer, received $9.9M in total, which increased by 1% compared to 2018. 50% of Jonas' compensation, or $5M, was in option awards. Jonas also received $286K in non-equity incentive plan, $681K in salary, $3.9M in stock awards, as well as $17K in other compensation.
For fiscal year 2019, the median employee pay was $369,650 at Sage Therapeutics. Therefore, the ratio of Jeffrey M. Jonas' pay to the median employee pay was 27 to one.
Michael Cloonan, Chief Business Officer, received a compensation package of $5M, which increased by 19% compared to previous year. 49% of the compensation package, or $2.4M, was in option awards.
Stephen J. Kanes, Chief Medical Officer, earned $4M in 2019, a 22% increase compared to previous year.
Anne Marie Cook, General Counsel, received $4M in 2019, which increases by 8% compared to 2018.
Albert J. Robichaud, Chief Scientific Officer, earned $4M in 2019, a 8% increase compared to previous year.
Kimi Iguchi, Chief Financial Officer, received $3.9M in 2019, which increases by 8% compared to 2018.
Related executives
Albert Robichaud
Sage Therapeutics
Chief Scientific Officer
Jeffrey Jonas
Sage Therapeutics
Chief Innovation Officer
Kimi Iguchi
Sage Therapeutics
Chief Financial Officer
Michael Cloonan
Sage Therapeutics
Chief Operating Officer
Anne Cook
Sage Therapeutics
General Counsel
Stephen Kanes
Sage Therapeutics
Chief Medical Officer
You may also like
Source: SEC filing on April 29, 2021.